New hope for toddlers with sickle cell: drug may stop painful attacks
Prevention
Recruiting now
This study looks at whether a liquid medicine called Xromi (hydroxycarbamide) can safely prevent painful complications of sickle cell disease in children aged 9 months to 2 years. About 180 children will take part, with some receiving Xromi and a comparison group of similar child…
Sponsor: Nova Laboratories Limited • Aim: Prevention
Last updated Jun 27, 2026 09:11 UTC